Chronic Myelomonocytic Leukemia Completed Phase 2 Trials for Decitabine (DB01262)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01251627Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic LeukemiaTreatment
NCT00067808Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)Treatment
NCT01098084Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML)